ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2015

Feb 26, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2015-02-23

Reporting Person: Pitango Venture Capital Principals Fund IV, L.P. (10% Owner)
Reporting Person: Pitango Venture Capital Fund IV, L.P. (10% Owner)
Reporting Person: Pitango V.C. Fund IV, L.P. (10% Owner)
Reporting Person: Pitango G.C. Capital Holdings Ltd. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-23	Common Stock	C	847424	—	Acquired	1042066	Indirect
2015-02-23	Common Stock	C	38143	—	Acquired	1080209	Indirect
2015-02-23	Common Stock	P	212375	$6.00	Acquired	1292584	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-23	Series AA Convertible Preferred Stock	$	C	2676348	Disposed		Common Stock (847424)	Indirect
2015-02-23	Convertible Promissory Notes	$	C	225747.43	Disposed		Common Stock (38143)	Indirect

Footnotes

F1: Consists of the following shares of Common Stock issued upon conversion of shares of Series AA Convertible Preferred Stock ("Series AA") and accrued and unpaid dividends thereon, on a 4.05783-for-1 basis, upon the closing of the Issuer's initial public offering: (i) 829,520 shares held directly by Pitango Venture Capital Fund IV L.P. ("Pitango Fund IV"), and (ii) 17,904 shares held directly by Pitango Venture Capital Fund Principals IV L.P. ("Pitango Principals IV"). The shares of Series AA had no expiration date.

F2: Pitango V.C. Fund IV, L.P. is the General Partner of Pitango Fund IV and Pitango Principals IV, with its own General Partner being Pitango G.P. Capital Holdings Ltd., an Israeli company, owned indirectly by six individuals. These six individuals share voting and dispositive power of the Isuer's shares but none has sole voting or dispositive power of the Issuer's shares.

F3: The outstanding principal amount and all accrued and unpaid interest under the Convertible Promissory Notes were automatically converted upon the closing of the Issuer's initial public offering into shares of Common Stock at the initial public offering price of $6.00 per share. The Convertible Promissory Notes had no expiration date. The number of shares of Common Stock as shown in column 4 of Table I consists of the following: (i) 37,337 shares held directly by Pitango Fund IV, and (ii) 806 shares held directly by Pitango Principals IV.

F4: Consists of the following shares purchased at the Issuer's initial public offering: (i) 207,886 shares held directly by Pitango Fund IV, and (ii) 4,489 shares held directly by Pitango Principals IV.